Landmark Statin Trials Across the Spectrum of Risk: Secondary Stroke Prevention
Slide lecture program (12 slides): View & Download
- Simvastatin in Patients With Prior Cerebrovascular Disease: HPS
- SPARCL Trial of Secondary StrokePrevention: Study Design
- SPARCL Primary End Point: Time to Fatal or Nonfatal Stroke
- SPARCL Secondary End Point:Time to Major Coronary Event
- SPARCL: Benefit/Risk
- Effect of Atorvastatin on Stroke In SPARCL Patients with Diabetes
- SPARCL: Stroke in Patients With Carotid Stenosis
- SPARCL: Carotid Endarterectomy inPatients with Carotid Stenosis
- SPARCL: Prespecified andPost-Hoc Analyses
- SPARCL: Ischemic and Hemorrhagic Stroke Post hoc Analysis
- SPARCL: Multivariable Cox RegressionModel Baseline Characteristics
Click on slides to preview
Download slides below
Share this page with your colleagues and friends: